 French Tribune | FDA adds 2 more approved uses for Amgen's Prolia BusinessWeek Biotechnology company Amgen Inc. said Monday the Food and Drug Administration has approved its osteoporosis treatment Prolia to help make bones stronger in some cancer patients who have had chemotherapy. The Thousand Oaks, Calif., company said … FDA Okays Denosumab for Cancer-Induced Bone Loss FDA approves 2 new indications for denosumab FDA Approves Denosumab for Patients With Cancer |
FDA adds 2 more approved uses for Amgen’s Prolia – BusinessWeek
September 20, 2011
